The Latest in Hematology Times

Combo is preferentially active in T-cell lymphomas

February 7, 2018

FDA expands approved use of ferumoxytol injection

February 7, 2018

Duvelisib combos show promise for PTCL, CTCL

February 7, 2018

Analysis reveals potential MM risk variants

February 6, 2018

Multiple Myeloma

FDA investigating VTEs related to ECP

February 6, 2018

Mogamulizumab is ‘valuable’ option for CTCL

February 5, 2018

Socioeconomic deprivation tied to survival in ALL

February 4, 2018

In situ vaccination eradicates lymphoma, other cancers

February 3, 2018

Combo could treat double-hit lymphoma

February 2, 2018

Interim trial results may be misleading

February 2, 2018

Related Issues

CAR T-cell therapy produces durable CRs in ALL

February 1, 2018

FDA places T-cell therapy on clinical hold

February 1, 2018

IV bevacizumab improves severe bleeding in HHT

January 31, 2018

Trial protocols redacted by industry sponsors

January 31, 2018

Related Issues

No need for structured PE assessment, team says

January 30, 2018

Thrombosis